ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Plasma levels of adiponectin have been shown to be decreased in obesity, insulin resistance, and type 2 diabetes, while adiponectin replenishment has been shown to improve insulin resistance and impaired glucose tolerance in mice18–21.